Renaissance Technologies’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-459,300	Closed	-$2.38M	–	3985
2024 Q3	$2.38M	Sell	459,300 -112,700	-20%	-$560K	﹤0.01%	1897
2024 Q2	$1.47M	Buy	572,000 +198,300	+53%	+$677K	﹤0.01%	2082
2024 Q1	$1.84M	Buy	+373,700	New	+$2.21M	﹤0.01%	2084
2023 Q4	–	Sell	-178,500	Closed	-$2.05M	–	4219
2023 Q3	$2.05M	Sell	178,500 -32,017	-15%	-$616K	﹤0.01%	1843
2023 Q2	$5.33M	Buy	+210,517	New	+$6.56M	0.01%	1399
2020 Q2	–	Sell	-472,700	Closed	-$7M	–	3832
2020 Q1	$7M	Sell	472,700 -204,773	-30%	-$4.24M	0.01%	1374
2019 Q4	$11M	Sell	677,473 -198,900	-23%	-$3.08M	0.01%	1385
2019 Q3	$11.4M	Sell	876,373 -454,600	-34%	-$5.56M	0.01%	1306
2019 Q2	$17.3M	Buy	1,330,973 +428,900	+48%	+$5.41M	0.02%	1052
2019 Q1	$14.2M	Buy	902,073 +330,200	+58%	+$5.73M	0.01%	1169
2018 Q4	$11.5M	Buy	571,873 +395,419	+224%	+$8.71M	0.01%	1216
2018 Q3	$4.38M	Sell	176,454 -58,746	-25%	-$1.6M	﹤0.01%	1890
2018 Q2	$6.46M	Buy	235,200 +85,300	+57%	+$2.56M	0.01%	1613
2018 Q1	$4.62M	Buy	149,900 +61,944	+70%	+$1.99M	0.01%	1867
2017 Q4	$3.14M	Buy	87,956 +8,164	+10%	+$234K	﹤0.01%	2086
2017 Q3	$2.2M	Sell	79,792 -30,581	-28%	-$741K	﹤0.01%	2255
2017 Q2	$2.91M	Buy	+110,373	New	+$2.46M	﹤0.01%	2048
2016 Q1	–	Sell	-215,900	Closed	-$7.38M	–	3562
2015 Q4	$7.38M	Buy	215,900 +128,400	+147%	+$4.45M	0.02%	1191
2015 Q3	$2.6M	Sell	87,500 -41,000	-32%	-$1.25M	0.01%	1830
2015 Q2	$4.11M	Buy	128,500 +63,091	+96%	+$1.62M	0.01%	1569
2015 Q1	$1.36M	Buy	+65,409	New	+$1.13M	﹤0.01%	2146